Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 830.55 | 759.00 | 1922.63 | 0.3948 | -0.0717 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 2438.00 | 1922.63 | 1.2681 | 1.4333 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 795.00 | 1922.63 | 0.4135 | -0.0355 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 1656.00 | 1922.63 | 0.8613 | 0.7680 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1747.00 | 1922.63 | 0.9087 | 0.8479 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2058.00 | 1922.63 | 1.0704 | 1.1156 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2294.00 | 1922.63 | 1.1932 | 1.3140 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 1250.00 | 830.55 | 1708.00 | 1922.63 | 0.8884 | 0.8138 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 830.55 | 1876.00 | 1922.63 | 0.9758 | 0.9599 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 614.00 | 1922.63 | 0.3194 | -0.2208 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 830.55 | 526.00 | 1922.63 | 0.2736 | -0.3142 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1674.00 | 1922.63 | 0.8707 | 0.7839 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1676.00 | 1922.63 | 0.8717 | 0.7857 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 1250.00 | 830.55 | 1493.00 | 1922.63 | 0.7765 | 0.6230 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 2037.00 | 1922.63 | 1.0595 | 1.0978 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2057.00 | 1922.63 | 1.0699 | 1.1147 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 987.00 | 1922.63 | 0.5134 | 0.1532 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2138.00 | 1922.63 | 1.1120 | 1.1833 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 1250.00 | 830.55 | 885.00 | 1922.63 | 0.4603 | 0.0538 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1457.00 | 1922.63 | 0.7578 | 0.5907 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 830.55 | 1710.00 | 1922.63 | 0.8894 | 0.8155 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1976.00 | 1922.63 | 1.0278 | 1.0457 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1891.00 | 1922.63 | 0.9836 | 0.9728 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 830.55 | 2094.00 | 1922.63 | 1.0891 | 1.1461 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 830.55 | 905.00 | 1922.63 | 0.4707 | 0.0735 |